447 related articles for article (PubMed ID: 37047140)
1. The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology.
Zhang Q; Zhang S; Chen J; Xie Z
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047140
[TBL] [Abstract][Full Text] [Related]
2. Integrin-mediated cancer progression as a specific target in clinical therapy.
Chen JR; Zhao JT; Xie ZZ
Biomed Pharmacother; 2022 Nov; 155():113745. PubMed ID: 36182738
[TBL] [Abstract][Full Text] [Related]
3. From kinetics and cellular cooperations to cancer immunotherapies.
Trautmann A
Oncotarget; 2016 Jul; 7(28):44779-44789. PubMed ID: 27014912
[TBL] [Abstract][Full Text] [Related]
4. Roles of the immune system in cancer: from tumor initiation to metastatic progression.
Gonzalez H; Hagerling C; Werb Z
Genes Dev; 2018 Oct; 32(19-20):1267-1284. PubMed ID: 30275043
[TBL] [Abstract][Full Text] [Related]
5. Exosomes as mediators of immune regulation and immunotherapy in cancer.
Kugeratski FG; Kalluri R
FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
[TBL] [Abstract][Full Text] [Related]
6. CD47: role in the immune system and application to cancer therapy.
Hayat SMG; Bianconi V; Pirro M; Jaafari MR; Hatamipour M; Sahebkar A
Cell Oncol (Dordr); 2020 Feb; 43(1):19-30. PubMed ID: 31485984
[TBL] [Abstract][Full Text] [Related]
7. Histamine in cancer immunology and immunotherapy. Current status and new perspectives.
Sarasola MP; Táquez Delgado MA; Nicoud MB; Medina VA
Pharmacol Res Perspect; 2021 Oct; 9(5):e00778. PubMed ID: 34609067
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of the Immune System in Bone Metastasis Pathogenesis.
Xiang L; Gilkes DM
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602
[TBL] [Abstract][Full Text] [Related]
9. [Suppressor cells - the basis of the immunopathogenesis of cancer].
Kozlov VA
Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899
[TBL] [Abstract][Full Text] [Related]
10. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.
Lu M; Huang B; Hanash SM; Onuchic JN; Ben-Jacob E
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4165-74. PubMed ID: 25246552
[TBL] [Abstract][Full Text] [Related]
11. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy.
Peterson EE; Barry KC
Front Immunol; 2020; 11():621254. PubMed ID: 33613552
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
Williams KM; Gress RE
Best Pract Res Clin Haematol; 2008 Sep; 21(3):579-96. PubMed ID: 18790456
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironments, the immune system and cancer survival.
Strausberg RL
Genome Biol; 2005; 6(3):211. PubMed ID: 15774034
[TBL] [Abstract][Full Text] [Related]
14. The immune system and cancer evasion strategies: therapeutic concepts.
Muenst S; Läubli H; Soysal SD; Zippelius A; Tzankov A; Hoeller S
J Intern Med; 2016 Jun; 279(6):541-62. PubMed ID: 26748421
[TBL] [Abstract][Full Text] [Related]
15. An Individualized Immune Prognostic Index is a Superior Predictor of Survival of Hepatocellular Carcinoma.
Wang X; Wu Y; Wen D; Wu LY; Zhao Y; He Y; Yang H
Med Sci Monit; 2020 May; 26():e921786. PubMed ID: 32527991
[TBL] [Abstract][Full Text] [Related]
16. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-derived exosomes for cancer therapy.
Pitt JM; André F; Amigorena S; Soria JC; Eggermont A; Kroemer G; Zitvogel L
J Clin Invest; 2016 Apr; 126(4):1224-32. PubMed ID: 27035813
[TBL] [Abstract][Full Text] [Related]
18. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol.
Qomlaqi M; Bahrami F; Ajami M; Hajati J
Math Biosci; 2017 Oct; 292():1-9. PubMed ID: 28713023
[TBL] [Abstract][Full Text] [Related]
19. [Immune system and tumors].
Terme M; Tanchot C
Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
[TBL] [Abstract][Full Text] [Related]
20. Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.
Dodagatta-Marri E; Ma HY; Liang B; Li J; Meyer DS; Chen SY; Sun KH; Ren X; Zivak B; Rosenblum MD; Headley MB; Pinzas L; Reed NI; Del Cid JS; Hann BC; Yang S; Giddabasappa A; Noorbehesht K; Yang B; Dal Porto J; Tsukui T; Niessen K; Atakilit A; Akhurst RJ; Sheppard D
Cell Rep; 2021 Jul; 36(1):109309. PubMed ID: 34233193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
